Stocks
iShares U.S. Pharmaceuticals ETFIHE
AMEXHealthcarePharmaceuticals$86.56-0.12%
Price as of · delayed, not real-time
An exchange-traded fund that provides exposure to U.S. pharmaceutical companies, offering investors a way to track the performance of the sector. It is widely monitored for insights into healthcare market trends and pharmaceutical industry dynamics.
Market Cap: $671.1M52W Range: $58.97 – $92.30
Congressional Interest in iShares U.S. Pharmaceuticals ETF (IHE)
4 members of Congress have disclosed 5 trades in iShares U.S. Pharmaceuticals ETF (IHE), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
4
Buys
2
Sells
3
Who in Congress Is Trading IHE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-02-03 | ROBERT J. WITTMAN | buy | $1K – $15K |
| 2018-01-31 | William Cassidy | sell | $1K – $15K |
| 2015-08-27 | William Cassidy | buy | $1K – $15K |
| 2015-07-27 | Rubén Hinojosa | sell | $1K – $15K |
| 2015-02-04 | MICK MULVANEY | sell | $15K – $50K |